SCHEMBL14001096

SCHEMBL14001096

CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(Br)c(C(=O)OC)c(Br)c3)c(=O)n2C1c1ccc2c(c1)OCC2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.68
MEN1 O00255 6/20 0.61
KMT2A Q03164 6/20 0.61
NPSR1 Q6W5P4 4/20 0.61
ALDH1A1 P00352 3/20 0.61
MAPT P10636 3/20 0.61
USP2 O75604 2/20 0.61
HPGD P15428 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
HSD17B10 Q99714 2/20 0.61
KDM4E B2RXH2 1/20 0.61
LMNA P02545 1/20 0.61
CSNK2A2 P19784 2/20 0.55
CSNK2B P67870 2/20 0.55
CSNK2A1 P68400 2/20 0.55
P2RX3 P56373 1/20 0.53
TNF P01375 1/20 0.52
IL6 P05231 1/20 0.52
PTPN7 P35236 3/20 0.50
DUSP3 P51452 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14001099 0.88 CDC25B (0.71) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001156 0.86 CSNK2A2 (0.72) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001085 0.84 CDC25B (0.67) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001089 0.84 ALDH1A1 (0.62) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001185 0.82 CDC25B (0.65) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001188 0.82 CDC25B (0.65) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001182 0.82 CDC25B (0.60) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL4668961 0.81 CDC25B (1.00) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL4668964 0.81 CDC25B (1.00) CDC25BMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14001186 0.80 CDC25B (0.68) CDC25BMEN1KMT2ANPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008149311-A1 USE OF DERIVATIVES OF 3-OXO-2,3-DIHYDRO-5H-THIAZOLOF[3,2-A]PYRIMIDINE OR OF 3-OXO-2,3-DIHYDRO-5H-SELENAZOLO[3,2-A]PYRIMIDINE OR OF 3-OXO-1,2,3-TRIHYDRO-5H-IMIDAZOLO[1,2-A]PYRIMIDINE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF CANCER INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-11 WO disclosed